Description
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This peptide is an analog of a sequence of HIV-1 for which cytotoxic T lymphocytes may bind.
| Purity | ≥98% |
|---|---|
| Formula | C108H167N27O29 |
| Formula Wt. | 2307.67 |
| Synonym | HIV Endonuclease Antigenic Site; HIV Endonuclease. |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Rahman MA, Kuse N, Murakoshi H, et al. Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition. Microbes Infect. 2014 May;16(5):434-8. PMID: 24657622.
Neuroprotective flavonoid
Nucleoside (thymidine) analog; DNA chain termin...
Thrombin substrate used to measure thrombin act...
Galactose analog, allolactose mimic, induces ac...
Microtubule depolymerization inhibitor.
Mycotoxin produced by Fusarium fungi that infec...
V600E B-Raf inhibitor.
Amino amide; voltage-gated Na+, BK/SK, Kv1, Kv3...
PI3K and PDK1 inhibitor.
Endogenous calcitonin-family peptide, involved ...
BCL-XL specific degrader
Diterpene found in Taxus; potential microtubule...
MET inhibitor.
Vitamin A metabolite, differentiation inducer; ...
Endogenous peptide, produced by activation of P...
Antiviral againt SARS-CoV-2
Flavanone found in species of Citrus. Naringen...
Endogenous neuropeptide, also known as substanc...
ROCK inhibitor.
Endogenous cardiomodulatory peptide; NPR-A agon...